journal article·2025-10Open access

Real-time magnetic resonance visualization of tumor acidosis as a precognition indicator of therapeutic efficacy

Mengyao Mu, Mengmeng Zhang, Jie Liu, Ke Ren, Hui Liu, Lixian Yip, Kai Guo, Feifei Teng, Jian Dong, Xueli Xu, David Tai Leong, Xiao Sun

Abstract

Traditional antitumor strategies often require sufficient time to assess the effectiveness according to changes in tumor structure. Once ineffective, patients may miss the critical window for pursuing alternative treatment options. Herein, a manganese sulfide nanoplatform loaded with proton pump inhibitor (PPI) is developed. This nanoplatform is designed for visualizing tumor acidosis degree by magnetic resonance imaging (MRI), achieving real-time therapeutic efficacy precognition. The nanoplatform releases PPI, H 2 S, and Mn 2+ within the acidic lysosome of tumor cells. PPI inhibits V-ATPase expression, leading to an increase in intracellular H + levels. H 2 S accelerates glucose consumption of tumor cells, producing more lactic acid and further inducing tumor acidosis. Tumor acidosis in turn accelerates the nanoplatform's degradation, achieving higher tumor MRI. As the tumor acidosis degree correlates positively with tumor regression, real-time visualization of acidosis degree effectively predicts future therapeutics. Interestingly, tumor acidosis achieves efficient tumor metastasis suppression rather than increases it. Overall, this work presents a nanoplatform capable of visualizing tumor acidosis in real-time and precisely predicting future therapeutics.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced MRI Techniques and Applications · Lanthanide and Transition Metal Complexes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (40)

Show source-provided references
1. Sight and switch off: nerve density visualization for interventions targeting nerves in prostate cancer10.1126/sciadv.aax6040 ↗
2. J. Zheng, J. Zhang, T. Zhang, Y. Yan, S. Bi, Automatic metabolism modulator for glycolytic intervention-induced cascade cancer therapy, BMEMat 3(1) e12125.10.1002/bmm2.12125 ↗
3. Noninvasive imaging of tumor glycolysis and chemotherapeutic resistance via de novo design of molecular afterglow scaffold10.1021/jacs.3c09473 ↗
4. Cell-programmed nutrient partitioning in the tumour microenvironment10.1038/s41586-021-03442-1 ↗
5. Reactive glycolysis metabolite-activatable nanotheranostics for NIR-II fluorescence imaging-guided phototherapy of cancer10.1002/adfm.202200016 ↗
6. Regulation of the mammalian-brain V-ATPase through ultraslow mode-switching10.1038/s41586-022-05472-9 ↗
7. Pharmacological targeting of vacuolar H+-ATPase via subunit V1G combats multidrug-resistant cancer10.1016/j.chembiol.2020.06.011 ↗
8. Lithium carbonate revitalizes tumor-reactive CD8+ T cells by shunting lactic acid into mitochondria10.1038/s41590-023-01738-0 ↗
9. A metabolic acidity-activatable calcium phosphate probe with fluorescence signal amplification capabilities for non-invasive imaging of tumor malignancy10.1016/j.scib.2021.11.003 ↗
10. Tumor-acidity-cleavable maleic acid amide (tacmaa): a powerful tool for designing smart nanoparticles to overcome delivery barriers in cancer nanomedicine10.1021/acs.accounts.8b00195 ↗
11. Zwitterion-based hydrogen sulfide nanomotors induce multiple acidosis in tumor cells by destroying tumor metabolic symbiosis10.1002/anie.202104304 ↗
12. Biodegradable ferrous sulfide-based nanocomposites for tumor theranostics through specific intratumoral acidosis-induced metabolic symbiosis disruption10.1021/jacs.2c07669 ↗
13. V-ATPase inhibitors and implication in cancer treatment, Cancer Treat
14. V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis10.7150/thno.28391 ↗
15. Proton pump inhibitors reduce pancreatic adenocarcinoma progression by selectively targeting H+, K+-ATPases in pancreatic cancer and stellate cells10.3390/cancers12030640 ↗
16. Proton pump inhibitors enhance macropinocytosis-mediated extracellular vesicle endocytosis by inducing membrane v-ATPase assembly10.1002/jev2.12426 ↗
17. Biomimetic copper single-atom nanozyme system for self-enhanced nanocatalytic tumor therapy10.1007/s12274-022-4359-6 ↗
18. Tumor-selective biodegradation-regulated photothermal H2S donor for redox dyshomeostasis- and glycolysis disorder-enhanced theranostics
19. Current advances on nanomaterials interfering with lactate metabolism for tumor therapy10.1002/advs.202305662 ↗
20. H2S and NIR light-driven nanomotors induce disulfidptosis for targeted anticancer therapy by enhancing disruption of tumor metabolic symbiosis10.1016/j.cclet.2024.110314 ↗
21. Dual key co-activated nanoplatform for switchable MRI monitoring accurate ferroptosis-based synergistic therapy10.1016/j.chempr.2022.03.009 ↗
22. A novel CRISPR/Cas9-Encapsulated biomimetic manganese sulfide nanourchins for targeted magnetic resonance contrast enhancement and self-enhanced chemodynamics-gene-immune synergistic tumor therapy
23. ICG/Lecithin: a promising theranostic agent for simultaneous therapy and diagnosis of MRI and PAI10.1016/j.cclet.2022.108068 ↗
24. Tumor microenvironment-tailored nanoplatform for companion diagnostic applications of precise cancer therapy10.1016/j.chempr.2023.06.011 ↗
25. Acidic tumor microenvironment-activated MRI nanoprobes for modulation and visualization of anti-PD-L1 immunotherapy10.1016/j.nantod.2023.102146 ↗
26. Tumor microenvironment-responsive intelligent nanoplatforms for cancer theranostics10.1016/j.nantod.2020.100851 ↗
27. Stimuli-responsive switchable MRI nanoprobe for tumor theranostics10.1016/j.nantod.2023.101931 ↗
28. Doping engineering to modulate lattice and electronic structure for enhanced piezocatalytic therapy and ferroptosis10.1002/adma.202304262 ↗
29. In situ encapsulating α-MnS into N,S-codoped nanotube-like carbon as advanced anode material: α → β phase transition promoted cycling stability and superior Li/Na-storage performance in half/full cells10.1002/adma.201706317 ↗
30. Superior lithium storage capacity of α-MnS nanoparticles embedded in S-doped carbonaceous mesoporous frameworks10.1002/aenm.201902077 ↗
31. Light-free generation of singlet oxygen through manganese-thiophene nanosystems for pH-responsive chemiluminescence imaging and tumor therapy10.1016/j.chempr.2020.06.024 ↗
32. Tumor-derived exosomes co-delivering aggregation-induced emission luminogens and proton pump inhibitors for tumor glutamine starvation therapy and enhanced type-I photodynamic therapy10.1016/j.biomaterials.2022.121462 ↗
33. Multistage tumor microenvironment-responsive theranostic nanopeanuts: toward multimode imaging guided chemo-photodynamic therapy10.1016/j.cej.2019.123893 ↗
34. Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses10.1038/s41467-017-01050-0 ↗
35. MnO2 gatekeeper: an intelligent and O2-evolving shell for preventing premature release of high cargo payload core, overcoming tumor hypoxia, and acidic H2O2-sensitive MRI10.1002/adfm.201604258 ↗
36. All-in-One theranostic nanoagent with enhanced reactive oxygen species generation and modulating tumor microenvironment ability for effective tumor eradication10.1021/acsnano.8b01893 ↗
37. Strategies to engineer various nanocarrier-based hybrid catalysts for enhanced chemodynamic cancer therapy10.1039/D3CS00356F ↗
38. Light-activatable liposomes for repetitive on-demand drug release and immunopotentiation in hypoxic tumor therapy10.1016/j.biomaterials.2020.120456 ↗
39. Enzyme-triggered chemodynamic therapy via a peptide-H2S donor conjugate with complexed Fe210.1002/anie.202302303 ↗
40. Tumor-specific carrier-free nanodrugs with GSH depletion and enhanced ROS generation for endogenous synergistic anti-tumor by a chemotherapy-photodynamic therapy10.1016/j.cej.2020.127212 ↗